Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapSuper Stock
    All News

    Brief: HLS Therapeutics Q4 2018 Revenue Was $16.7 Mln Compared To $20.4 Mln In Q4 2017

    Picture of HLS Therapeutics logoHLS Therapeutics
    21/03/2019 10:42
    March 21 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS ANNOUNCES Q4 AND YEAR-END 2018 FINANCIAL
RESULTS
    * Q4 2018 REVENUE WAS $16.7 MILLION COMPARED TO $20.4
MILLION IN
Q4 2017
    * Q4 2018 NET INCOME OF $0.4 MILLION, OR $0.01 PER COMMON
SHARE
    * Q4 2018 ADJUSTED EBITDA WAS $11.2 MILLION COMPARED TO
$15.5
MILLION IN Q4 2017

Source text for Eikon:  ID:nCNWYBYYca 
Further company coverage:  HLS.TO 

 (((Reuters.Briefs@thomsonreuters.com);;))

    Recent news on HLS Therapeutics

    See all news